Herpes zoster after COVID-19 vaccination: A case series
- Author:
Christine E. de Guia
1
;
Ivy S. Cagulada
1
;
Jonella Jean F. Nicolas
1
;
Cecilia R. Rosete
1
;
Czarina P. Chavez
1
;
DipClinRes
1
Author Information
- Publication Type:Other Types
- MeSH: COVID-19 Vaccines; Herpes Zoster; COVID-19
- From: Journal of the Philippine Dermatological Society 2021;30(2):79-82
- CountryPhilippines
- Language:English
-
Abstract:
Introduction:The coronavirus disease 2019 (COVID-19) pandemic caused a global health crisis, necessitating the development
of vaccines. An emerging cutaneous reaction is herpes zoster.
Case Series:We present 7 cases of Filipino patients who developed herpes zoster after receiving the COVID-19 vaccine. Four patients received Sinovac Biotech Ltd (CoronaVac), 2 patients received Oxford AstraZeneca, and 1 patient received Pfizer-BioN- Tech (COMIRNATY). Five patients developed herpes zoster after their first dose of the vaccine, while 2 patients developed herpes zoster after their second dose. All patients were prescribed anti-viral medication, after which resolution of the lesions was observed.
Conclusion:As more vaccines are administered, further surveillance is necessary to expand our understanding of a possible association between herpes zoster and COVID-19 vaccines. Additionally, awareness of cutaneous reactions following COVID-19 vaccines and their disease course can contribute to shifting the attitude towards pro-vaccination. - Full text:17_JPDS_DEGUIA_V2.pdf
